SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision

Why is clinical evidence insufficient to establish LRP1's contribution to AD development?

OPEN

Despite 25 years of research and promising preclinical results, clinical studies haven't provided sufficient evidence for LRP1's role in AD. This translation gap limits therapeutic development targeting LRP1. Gap type: open_question Source paper: Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies. (2017, J Lipid Res, PMID:28381441)

Priority: 0.78 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Why is clinical evidence insufficient to establish LRP1's contribution to AD development? is a 0.78 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why is clinical evidence insufficient to establish LRP1's contribution to AD development? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (1)

LRP1→Notch Signaling Activation

associated with (11)

entities-histone-methylation→ADentities-atp7b-gene→ADentities-ros→ADALZHEIMER'S DISEASE→LRP1LRP1→Alzheimer'S Disease
▸ Show 6 more

causes (1)

AD→neurodegeneration

data in (5)

benchmark_ot_ad_answer_key:LRP1→LRP1LRP1→benchmark_ot_ad_answer_key:LRP1ds-83b31ef18d49→LRP1ds-6784494f1741→LRP1LRP1→ds-6784494f1741

encodes (1)

LRP1→LRP1

expressed in (4)

endothelial cells→LRP1astrocytes→LRP1LRP1→Endothelial CellsLRP1→Astrocytes

indicates AB clearance capacity (1)

H3_LRP1→LRP1

inhibits (1)

LRP1→neuronal ferroptosis

mediates (4)

LRP1→Notch Pathway ActivationLRP1→Notch PathwayLRP1→ApoE_transportLRP1→DELTA LIGANDS

mediates ubiquitination (1)

LRP1→Delta ligands

provides data for (2)

LRP1→ds-83b31ef18d49LRP1→ds-6784494f1741

regulates (8)

LRP1→AMYLOID-ΒLRP1→Amyloid-betaLRP1→pericyte survivalLRP1→DELTA LIGANDSEPSIN1→LRP1
▸ Show 3 more

risk factor for (2)

genetically at-risk individuals→ADAPOE ε4→AD

targets (4)

h-84808267→LRP1SDA-2026-04-02-gap-tau-prop-20260402003221-H001→LRP1h-7e0b5ade→LRP1h-b948c32c→LRP1

therapeutic target (1)

LRP1→Alzheimer

therapeutic target for (2)

TREM2→ADCCR2→AD

upregulates (1)

LRP1→M2-like Macrophage Polarization
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps